Is JSPR or KYMR more undervalued in 2026?

CirclFi compares Jasper Therapeutics, Inc. (JSPR) and Kymera Therapeutics, Inc. (KYMR) using 13 institutional-grade valuation models. JSPR has a Quality of Company score of 3.5/10 while KYMR scores 7.2/10.

Which is a better buy — JSPR or KYMR?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do JSPR and KYMR valuations compare?

JSPR at $0.83 and KYMR at $81.42 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

JSPR vs KYMR Valuation Comparison 2026 — Intrinsic Value Analysis

JSPR

Biological Products, (No Diagnostic Substances)

Jasper Therapeutics, Inc.

Quality

3.5

out of 10

Value Trap

LOW

Price

$0.83

Last close

Models

7/13

Active

KYMR

Biological Products, (No Diagnostic Substances)

Kymera Therapeutics, Inc.

Quality

7.2

out of 10

Value Trap

LOW

Price

$81.42

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	JSPR Fair Value	JSPR Upside	KYMR Fair Value	KYMR Upside
Bayesian DCF	Intrinsic	$0.48	-42.0%	$18.29	-77.5%
Earnings Power Value	Intrinsic	—	—	$38.43	-54.7%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$2.18	+163.1%	$12.67	-84.4%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for JSPR vs KYMR — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

JSPR vs KYMR — Which Stock Is More Undervalued?

KYMR scores higher with a 7.2/10 quality rating vs JSPR's 3.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Jasper Therapeutics, Inc. (JSPR) and Kymera Therapeutics, Inc. (KYMR) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

JSPR currently trades at $0.83 with a QOC of 3.5/10, while KYMR trades at $81.42 with a QOC of 7.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).